ProMIS Neurosciences Inc. PMN
- PMN442 — Multiple System Atrophy Preclinical
- PMN442 — Dementia with Lewy Bodies Preclinical
- PMN442 — Parkinson's Disease Preclinical
- PMN440 Preclinical
Home › Targets › alpha-synuclein
Companies with an active program directed at alpha-synuclein.